BackResponse Genetics Overview

Response Genetics Total Liabilities

Track Response Genetics's total liabilities ($16M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$15.72M
↑ 31.80% YoYΔ $3.79M vs prior year quarter

Peer trimmed avg / median

Loading

Response Genetics Total Liabilities History

Loading

Response Genetics vs. peers: Total Liabilities Comparison

Loading

Response Genetics Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Response Genetics (RGDXQ) FAQ

Response Genetics (RGDXQ) currently reports a total liabilities of $16M as of March 2015. That compares with $12M in the prior-year period — up 31.8% year over year. Use the charts on this page to explore Response Genetics's total liabilities history and peer comparisons.

Response Genetics's total liabilities increased from $12M to $16M — a 31.8% year-over-year increase (period ending March 2015). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Response Genetics reported $16M in total liabilities as of March 2015. That compares with $12M in the prior-year period — up 31.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $16M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Response Genetics, and consider following RGDXQ for alerts when major investors trade the stock.